Is a complete CRDF research report available?

No complete published report is available for Cardiff Oncology, Inc. (CRDF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cardiff Oncology, Inc. (CRDF)

NASDAQ: CRDF · USD

$0.93

+0.05 (+6.3%)· Recorded snapshot

Market cap	72.3M
Revenue (ttm)	508K
Net income (ttm)	-40.1M
EPS (ttm)	-$0.59
Shares out	77.8M
Volume	266,877
Beta	1.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 508K
Net income (ttm): -40.1M
EPS (ttm): -$0.59
Market cap: 72.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001213037
Company name	Cardiff Oncology, Inc.
Country	United States
Country code	US
CUSIP number	14147L108
Earnings date	2026-11-09
Earnings time	amc
Employees	31
Employees change	-2
Employees growth	-6.06%
Enterprise value	$38.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US14147L1089
Last 10-K release date	2026-02-24
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2019-02-20
Last stock split type	Reverse
Market cap	$72.3M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$0.93
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CRDF
U.S. state	California
Website	https://www.cardiffoncology.com

Metric

Value

Amount currency

USD

CIK code

0001213037

Company name

Cardiff Oncology, Inc.

Country

United States

Country code

CUSIP number

14147L108

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

-2

Employees growth

-6.06%

Enterprise value

$38.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1999

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US14147L1089

Last 10-K release date

2026-02-24

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split date

2019-02-20

Last stock split type

Reverse

Market cap

$72.3M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$0.93

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CRDF

U.S. state

California

Website

https://www.cardiffoncology.com

Metric	Value
Earnings yield	-63.6%
EV/Sales	68.98x
FCF / EV yield	-116.76%
FCF yield	-59.21%
Forward EV/Sales	98.91x
Forward P/S	195.05x
P/B ratio	2.26x
P/S ratio	136.03x
Price / tangible book value	2.6x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-63.6%

EV/Sales

68.98x

FCF / EV yield

-116.76%

FCF yield

-59.21%

Forward EV/Sales

98.91x

Forward P/S

195.05x

P/B ratio

2.26x

P/S ratio

136.03x

Price / tangible book value

2.6x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-8,320.08%
Pretax margin	-7,884.06%
Profit per employee	$-1.3M
Revenue per employee	$16,387
ROA	-46.73%
ROA (5Y)	-26.53%
ROCE	-159.3%
ROE	-94.08%
ROE (5Y)	-46.09%
ROIC	-60.88%
SBC / revenue	1,028.54%

Metric

Value

Operating margin

-8,320.08%

Pretax margin

-7,884.06%

Profit per employee

$-1.3M

Revenue per employee

$16,387

ROA

-46.73%

ROA (5Y)

-26.53%

ROCE

-159.3%

ROE

-94.08%

ROE (5Y)

-46.09%

ROIC

-60.88%

SBC / revenue

1,028.54%

Metric	Value
EPS growth quarters	6
EPS growth years	1
Gross profit growth (Q)	-14.05%
Net income growth quarters	4
Net income growth years	0
Revenue growth	-6.79%
Revenue growth (Q)	-14.05%
Revenue growth (QoQ)	153.66%
Revenue growth 10Y	3.49%
Revenue growth 3Y	7.23%
Revenue growth 5Y	5.11%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth (Q)

-14.05%

Net income growth quarters

Net income growth years

Revenue growth

-6.79%

Revenue growth (Q)

-14.05%

Revenue growth (QoQ)

153.66%

Revenue growth 10Y

3.49%

Revenue growth 3Y

7.23%

Revenue growth 5Y

5.11%

Revenue growth years

Metric	Value
Capital expenditures	$-62,000
Depreciation and amortization	$351,000
EBIT	$-42.3M
EBITDA	$-41.9M
EPS	$-0.59
FCF per share	$-0.53
Financing cash flow	$2.8M
Free cash flow	$-40.9M
Free cash flow minus SBC	$-46.1M
Gross profit	$-34.8M
Investing cash flow	$36.4M
Net cash flow	$-1.6M
Net income	$-40.1M
Operating cash flow minus SBC	$-46.1M
Operating income	$-42.3M
Revenue	$508,000
Stock-based compensation	$5.2M

Metric

Value

Capital expenditures

$-62,000

Depreciation and amortization

$351,000

EBIT

$-42.3M

EBITDA

$-41.9M

EPS

$-0.59

FCF per share

$-0.53

Financing cash flow

$2.8M

Free cash flow

$-40.9M

Free cash flow minus SBC

$-46.1M

Gross profit

$-34.8M

Investing cash flow

$36.4M

Net cash flow

$-1.6M

Net income

$-40.1M

Operating cash flow minus SBC

$-46.1M

Operating income

$-42.3M

Revenue

$508,000

Stock-based compensation

$5.2M

Metric	Value
Altman Z-Score	-11.68
Book value per share	$0.39
Debt / equity	0.02
Long-term assets	$1.7M
Long-term liabilities	$0
Net cash (debt)	$34.1M
Net cash / market cap	49.29%
Net cash growth	-51.18%
Net debt / equity	-1.28
Piotroski F-Score	1
Property, plant and equipment	$810,000
Shareholders' equity	$26.5M
Tangible book value	$26.5M
Tangible book value per share	$0.39
Total assets	$37.3M
Total cash	$34.5M
Total debt	$457,000
Total liabilities	$10.8M
WACC	11.97%

Metric

Value

Altman Z-Score

-11.68

Book value per share

$0.39

Debt / equity

0.02

Long-term assets

$1.7M

Long-term liabilities

Net cash (debt)

$34.1M

Net cash / market cap

49.29%

Net cash growth

-51.18%

Net debt / equity

-1.28

Piotroski F-Score

Property, plant and equipment

$810,000

Shareholders' equity

$26.5M

Tangible book value

$26.5M

Tangible book value per share

$0.39

Total assets

$37.3M

Total cash

$34.5M

Total debt

$457,000

Total liabilities

$10.8M

WACC

11.97%

Metric	Value
Asset turnover	0.01
Current assets	$35.6M
Current liabilities	$10.8M
Current ratio	3.3
Net working capital	$-9.3M
Quick ratio	3.21
Working capital	$24.8M
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$35.6M

Current liabilities

$10.8M

Current ratio

3.3

Net working capital

$-9.3M

Quick ratio

3.21

Working capital

$24.8M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-15.77%
Dividend yield	0%
Shareholder yield	-15.77%

Metric

Value

Buyback yield / dilution

-15.77%

Dividend yield

Shareholder yield

-15.77%

Metric	Value
10Y price change	-99.68%
10Y return CAGR	-43.73%
10Y total return	-99.68%
150-day SMA	$1.29
15Y price change	-99.68%
15Y return CAGR	-31.78%
15Y total return	-99.68%
1D price change	6.26%
1M price change	-27.01%
1M total return	-27.01%
1W price change	-2.83%
1W total return	-2.83%
1Y price change	-60.48%
1Y return CAGR	-60.5%
1Y total return	-60.48%
20-day SMA	$0.99
200-day SMA	$1.46
20Y price change	-99.71%
20Y return CAGR	-25.37%
20Y total return	-99.71%
3M price change	8.28%
3M total return	8.28%
3Y price change	-13.8%
3Y return CAGR	-4.83%
3Y total return	-13.8%
50-day SMA	$1.08
50-day SMA vs 200-day SMA	50under200
52-week high	$3.31
52-week high date	2025-12-26
52-week low	$0.76
52-week low date	2026-07-29
5Y price change	-84.48%
5Y return CAGR	-31.11%
5Y total return	-84.48%
6M price change	-47.38%
6M total return	-47.38%
All-time high	$2,030.40
All-time high date	2005-06-08
All-time low	$0.70
All-time low date	2020-03-19
Average true range (ATR)	$0.08
Average volume	444.9K
Beta (1Y)	3.04
Beta (2Y)	1.28
Beta (5Y)	1.42
Change from 52-week high	-71.91%
Change from 52-week low	22.91%
Change from all-time high	-99.96%
Change from all-time low	29.12%
Change from open	8.24%
Day's gap	-1.83%
Dollar volume	$248,169
High price	$0.93
Low price	$0.86
Monthly RSI	39.42
Open price	$0.86
Position in 52-week range	100%
Premarket change	2.83%
Premarket close	$0.88
Premarket price	$0.90
Premarket volume	792
Previous close	$0.88
Price vs 150-day SMA	-29.73%
Price vs 20-day SMA	-8.63%
Price vs 200-day SMA	-37.88%
Price vs 50-day SMA	-16.27%
Relative volume	0.6
RSI	39.83
Sharpe ratio	-0.65
Sharpe ratio (3Y)	0.42
Sharpe ratio (5Y)	0.07
Sortino ratio	-0.76
Sortino ratio (3Y)	0.75
Sortino ratio (5Y)	0.17
Volume	266.9K
Weekly RSI	38.18
YTD price change	-67.79%
YTD total return	-67.79%

Metric

Value

10Y price change

-99.68%

10Y return CAGR

-43.73%

10Y total return

-99.68%

150-day SMA

$1.29

15Y price change

-99.68%

15Y return CAGR

-31.78%

15Y total return

-99.68%

1D price change

6.26%

1M price change

-27.01%

1M total return

-27.01%

1W price change

-2.83%

1W total return

-2.83%

1Y price change

-60.48%

1Y return CAGR

-60.5%

1Y total return

-60.48%

20-day SMA

$0.99

200-day SMA

$1.46

20Y price change

-99.71%

20Y return CAGR

-25.37%

20Y total return

-99.71%

3M price change

8.28%

3M total return

8.28%

3Y price change

-13.8%

3Y return CAGR

-4.83%

3Y total return

-13.8%

50-day SMA

$1.08

50-day SMA vs 200-day SMA

50under200

52-week high

$3.31

52-week high date

2025-12-26

52-week low

$0.76

52-week low date

2026-07-29

5Y price change

-84.48%

5Y return CAGR

-31.11%

5Y total return

-84.48%

6M price change

-47.38%

6M total return

-47.38%

All-time high

$2,030.40

All-time high date

2005-06-08

All-time low

$0.70

All-time low date

2020-03-19

Average true range (ATR)

$0.08

Average volume

444.9K

Beta (1Y)

3.04

Beta (2Y)

1.28

Beta (5Y)

1.42

Change from 52-week high

-71.91%

Change from 52-week low

22.91%

Change from all-time high

-99.96%

Change from all-time low

29.12%

Change from open

8.24%

Day's gap

-1.83%

Dollar volume

$248,169

High price

$0.93

Low price

$0.86

Monthly RSI

39.42

Open price

$0.86

Position in 52-week range

100%

Premarket change

2.83%

Premarket close

$0.88

Premarket price

$0.90

Premarket volume

792

Previous close

$0.88

Price vs 150-day SMA

-29.73%

Price vs 20-day SMA

-8.63%

Price vs 200-day SMA

-37.88%

Price vs 50-day SMA

-16.27%

Relative volume

0.6

RSI

39.83

Sharpe ratio

-0.65

Sharpe ratio (3Y)

0.42

Sharpe ratio (5Y)

0.07

Sortino ratio

-0.76

Sortino ratio (3Y)

0.75

Sortino ratio (5Y)

0.17

Volume

266.9K

Weekly RSI

38.18

YTD price change

-67.79%

YTD total return

-67.79%

Metric	Value
Float	75.4M
Float percentage	96.9%
Shares change (QoQ)	0.07%
Shares change (YoY)	15.77%
Shares held by insiders	3.1%
Shares held by institutions	25.03%
Shares outstanding	77.8M
Short % of float	16.08%
Short % of shares	15.58%
Short ratio	14.2 days

Metric

Value

Float

75.4M

Float percentage

96.9%

Shares change (QoQ)

0.07%

Shares change (YoY)

15.77%

Shares held by insiders

3.1%

Shares held by institutions

25.03%

Shares outstanding

77.8M

Short % of float

16.08%

Short % of shares

15.58%

Short ratio

14.2 days

Cardiff Oncology, Inc. (CRDF)

Price

Financial snapshot

Fair-value bridge

Latest news · CRDF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CRDF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CRDF

Frequently asked questions